AAAAAA

   
Results: 1-12 |
Results: 12
In vivo lymphoproliferation in the popliteal lymph node (PLN) assay can beinhibited by leflunomide's active metabolite A77 1726
Authors: Schorlemmer, HU Kurrle, R Schleyerbach, R Bartlett, RR
Citation: Hu. Schorlemmer et al., In vivo lymphoproliferation in the popliteal lymph node (PLN) assay can beinhibited by leflunomide's active metabolite A77 1726, INFLAMM RES, 48, 1999, pp. S111-S112
Disease-modifying activity of malononitrilamides, derivatives of leflunomide's active metabolite, on models of rheumatoid arthritis
Authors: Schorlemmer, HU Kurrle, R Schleyerbach, R Bartlett, RR
Citation: Hu. Schorlemmer et al., Disease-modifying activity of malononitrilamides, derivatives of leflunomide's active metabolite, on models of rheumatoid arthritis, INFLAMM RES, 48, 1999, pp. S113-S114
Cell cycle regulation and inhibition of de novo pyrimidine biosynthesis byleflunomide
Authors: Schorlemmer, HU Milbert, U Zeitter, D Haun, G Wunschel, M Bartlett, RR
Citation: Hu. Schorlemmer et al., Cell cycle regulation and inhibition of de novo pyrimidine biosynthesis byleflunomide, INFLAMM RES, 48, 1999, pp. S115-S116
Generation of O-2(-) radicals in macrophages can be inhibited in vitro andin vivo by derivatives of leflunomide's primary metabolite
Authors: Schorlemmer, HU Kurrle, R Schleyerbach, R Bartlett, RR
Citation: Hu. Schorlemmer et al., Generation of O-2(-) radicals in macrophages can be inhibited in vitro andin vivo by derivatives of leflunomide's primary metabolite, INFLAMM RES, 48, 1999, pp. S117-S118
Malononitrilamides prevent the generation of oxygen radicals in mononuclear phagocytes and graft rejection in a rat model
Authors: Schorlemmer, HU Bartlett, RR Kurrle, R
Citation: Hu. Schorlemmer et al., Malononitrilamides prevent the generation of oxygen radicals in mononuclear phagocytes and graft rejection in a rat model, TRANSPLAN P, 31(1-2), 1999, pp. 851-853
Coadministration of malononitrilamides and tacrolimus induces tolerance ina rat skin allograft model
Authors: Schorlemmer, HU Bartlett, RR Lindner, JK Kurrle, R
Citation: Hu. Schorlemmer et al., Coadministration of malononitrilamides and tacrolimus induces tolerance ina rat skin allograft model, TRANSPLAN P, 31(1-2), 1999, pp. 1184-1188
Inhibition of murine IgE and immediate cutaneous hypersensitivity responses to ovalbumin by the immunomodulatory agent leflunomide
Authors: Jarman, ER Kuba, A Montermann, E Bartlett, RR Reske-Kunz, AB
Citation: Er. Jarman et al., Inhibition of murine IgE and immediate cutaneous hypersensitivity responses to ovalbumin by the immunomodulatory agent leflunomide, CLIN EXP IM, 115(2), 1999, pp. 221-228
Chromatographic separation with subsequent detection of changes in conductivity as a useful tool to detect an increase in the L-dihydroorotic acid (L-DHO) content of cell lysates and serum
Authors: Milbert, U Schorlemmer, HU Haun, G Zeitter, D Wunschel, M Fudali, C Ruuth, E Bartlett, RR
Citation: U. Milbert et al., Chromatographic separation with subsequent detection of changes in conductivity as a useful tool to detect an increase in the L-dihydroorotic acid (L-DHO) content of cell lysates and serum, INT J IMM T, 14(4), 1998, pp. 223-232
Long-term allograft survival and tolerance induction by the synergistic activity of malononitrilamides and tacrolimus
Authors: Schorlemmer, HU Bartlett, RR Lindner, JK Kurrle, R
Citation: Hu. Schorlemmer et al., Long-term allograft survival and tolerance induction by the synergistic activity of malononitrilamides and tacrolimus, TRANSPLAN P, 30(8), 1998, pp. 4099-4103
Prevention of experimental autoimmune diabetes in mice by treatment with leflunomide
Authors: Stosic-Grujicic, S Dimitrijevic, M Bartlett, RR
Citation: S. Stosic-grujicic et al., Prevention of experimental autoimmune diabetes in mice by treatment with leflunomide, TRANSPLAN P, 30(8), 1998, pp. 4132-4133
Immunomodulatory activity of malononitrilamides, derivatives of leflunomide's primary metabolite, on models of experimental rheumatoid arthritis
Authors: Schorlemmer, HU Bartlett, RR Schleyerbach, R
Citation: Hu. Schorlemmer et al., Immunomodulatory activity of malononitrilamides, derivatives of leflunomide's primary metabolite, on models of experimental rheumatoid arthritis, TRANSPLAN P, 30(8), 1998, pp. 4137-4139
Modulation of immunoglobulin dysregulation in graft versus host- and systemic lupus erythematosus-like diseases by malononitrilamides
Authors: Schorlemmer, HU Bartlett, RR
Citation: Hu. Schorlemmer et Rr. Bartlett, Modulation of immunoglobulin dysregulation in graft versus host- and systemic lupus erythematosus-like diseases by malononitrilamides, TRANSPLAN P, 30(8), 1998, pp. 4153-4155
Risultati: 1-12 |